spacer
spacer

PDBsum entry 6a6t

Go to PDB code: 
Top Page protein ligands links
Oxidoreductase PDB id
6a6t
Contents
Protein chain
430 a.a.
Ligands
FAD
SO4 ×4
D1D ×5
Waters ×159

References listed in PDB file
Key reference
Title Creation of haemoglobin a1c direct oxidase from fructosyl peptide oxidase by combined structure-Based site specific mutagenesis and random mutagenesis.
Authors N.Ogawa, T.Kimura, F.Umehara, Y.Katayama, G.Nagai, K.Suzuki, K.Aisaka, Y.Maruyama, T.Itoh, W.Hashimoto, K.Murata, M.Ichimura.
Ref. Sci Rep, 2019, 9, 942. [DOI no: 10.1038/s41598-018-37806-x]
PubMed id 30700768
Abstract
The currently available haemoglobin A1c (HbA1c) enzymatic assay consists of two specific steps: proteolysis of HbA1c and oxidation of the liberated fructosyl peptide by fructosyl peptide oxidase (FPOX). To develop a more convenient and high throughput assay, we devised novel protease-free assay system employing modified FPOX with HbA1c oxidation activity, namely HbA1c direct oxidase (HbA1cOX). AnFPOX-15, a modified FPOX from Aspergillus nidulans, was selected for conversion to HbA1cOX. As deduced from the crystal structure of AnFPOX-15, R61 was expected to obstruct the entrance of bulky substrates. An R61G mutant was thus constructed to open the gate at the active site. The prepared mutant exhibited significant reactivity for fructosyl hexapeptide (F-6P, N-terminal amino acids of HbA1c), and its crystal structure revealed a wider gate observed for AnFPOX-15. To improve the reactivity for F-6P, several mutagenesis approaches were performed. The ultimately generated AnFPOX-47 exhibited the highest F-6P reactivity and possessed HbA1c oxidation activity. HbA1c levels in blood samples as measured using the direct assay system using AnFPOX-47 were highly correlated with the levels measured using the conventional HPLC method. In this study, FPOX was successfully converted to HbA1cOX, which could represent a novel in vitro diagnostic modality for diabetes mellitus.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer